PTGS2 and cancer: The typical non-selective NSAIDs, they block both COX-1 and COX-2 enzymes, while celecoxib selectively targets COX-2, which is general upregulated in inflammatory conditions and various malignant tumors (Tołoczko-Iwaniuk et al., 2019).